← Back to Search

Sildenafil administration for Patent Foramen Ovale

Phase < 1
Waitlist Available
Led By Andrew Lovering, PhD
Research Sponsored by University of Oregon
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 hour post intervention
Awards & highlights

Study Summary

This trial will study Croatian breath-hold and SCUBA divers to see if there is a relationship between PFO and IPAVA blood flow and to test if a placebo-controlled intervention (sildenafil) can reduce pulmonary arterial pressure.

Eligible Conditions
  • Patent Foramen Ovale
  • Intrapulmonary Arteriovenous Anastomosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 hour post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 hour post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Q-IPAVA
Concentration Of CRP
Concentration Of MMP-2
+11 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Sildenafil administrationActive Control1 Intervention
Administration of 50mg sildenafil one time, one hour prior to measurements
Group II: Placebo administrationPlacebo Group1 Intervention
Administration of 50mg placebo one time, one hour prior to measurements

Find a Location

Who is running the clinical trial?

University of OregonLead Sponsor
80 Previous Clinical Trials
46,677 Total Patients Enrolled
Andrew Lovering, PhDPrincipal InvestigatorUniversity of Oregon
1 Previous Clinical Trials
10 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~14 spots leftby Apr 2025